Cargando…

MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients

Human herpesvirus-6A (HHV-6A) and −6B (HHV-6B) might be involved in the etiopathogenesis of multiple sclerosis (MS), especially the HHV-6A. We aim at assessing, for the first time in the scientific literature, the HHV-6A/B microRNAs in MS patients. We analyzed the miRNAs of HHV-6A: miR-U86, and −6B:...

Descripción completa

Detalles Bibliográficos
Autores principales: Domínguez-Mozo, María I., Nieto-Guerrero, Alejandro, Pérez-Pérez, Silvia, García-Martínez, María Á., Arroyo, Rafael, Álvarez-Lafuente, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531184/
https://www.ncbi.nlm.nih.gov/pubmed/33072077
http://dx.doi.org/10.3389/fimmu.2020.02142
_version_ 1783589714835537920
author Domínguez-Mozo, María I.
Nieto-Guerrero, Alejandro
Pérez-Pérez, Silvia
García-Martínez, María Á.
Arroyo, Rafael
Álvarez-Lafuente, Roberto
author_facet Domínguez-Mozo, María I.
Nieto-Guerrero, Alejandro
Pérez-Pérez, Silvia
García-Martínez, María Á.
Arroyo, Rafael
Álvarez-Lafuente, Roberto
author_sort Domínguez-Mozo, María I.
collection PubMed
description Human herpesvirus-6A (HHV-6A) and −6B (HHV-6B) might be involved in the etiopathogenesis of multiple sclerosis (MS), especially the HHV-6A. We aim at assessing, for the first time in the scientific literature, the HHV-6A/B microRNAs in MS patients. We analyzed the miRNAs of HHV-6A: miR-U86, and −6B: hhv6b-miR-Ro6-1, −2, −3-3p, −3-5p, and −4 in paired samples of serum and CSF of 42 untreated MS patients and 23 patients with other neurological diseases (OND), using Taqman MicroRNA Assays. Intrathecal HHV-6A/B antibody production and anti-HHV-6A/B IgG/IgM levels in serum were measured. MS clinical data were available. We detected the following miRNAs: hhv6b-miR-Ro6-2 (serum: MS:97.7%, OND:95.7%; CSF: MS:81%, OND:86.4%), 3-3p (serum: MS:4.8%, OND:0%; CSF: MS:2.4%, OND:4.5%), −3-5p (serum: MS:95.2%, OND:91.3%; CSF: MS:50%, OND:54.5%), and miR-U86 (serum: MS:54.8%, OND:47.8%; CSF: MS:11.9%, OND:9.1%). In the serum of the whole population (MS and OND patients) we found a significant correlation between the levels of hhv6b-miR-Ro6-2 and −3-5p (Spearman r = 0.839, pcorr = 3E-13), −2 and miR-U86 (Spearman r = 0.578, pcorr = 0.001) and −3-5p and miR-U86 (Spearman r = 0.698, pcorr = 1.34E-5); also in the CSF, between hhv6b-miR-Ro6-2 and −3-5p (Spearman r = 0.626, pcorr = 8.52E-4). These correlations remained statistically significant when both populations were considered separately. The anti-HHV-6A/B IgG levels in CSF and the intrathecal antibody production in positive MS patients for hhv6b-miR-Ro6-3-5p were statistically significant higher than in the negative ones (pcorr = 0.006 and pcorr = 0.036). The prevalence of miR-U86 (30.8%) in the CSF of individuals without gadolinium-enhancing lesions was higher (p = 0.035) than in the ones with these lesions (0%); however, the difference did not withstand Bonferroni correction (pcorr = 0.105). We propose a role of HHV-6A/B miRNAs in the maintenance of the viral latency state. Further investigations are warranted to validate these results and clarify the function of these viral miRNAs.
format Online
Article
Text
id pubmed-7531184
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75311842020-10-17 MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients Domínguez-Mozo, María I. Nieto-Guerrero, Alejandro Pérez-Pérez, Silvia García-Martínez, María Á. Arroyo, Rafael Álvarez-Lafuente, Roberto Front Immunol Immunology Human herpesvirus-6A (HHV-6A) and −6B (HHV-6B) might be involved in the etiopathogenesis of multiple sclerosis (MS), especially the HHV-6A. We aim at assessing, for the first time in the scientific literature, the HHV-6A/B microRNAs in MS patients. We analyzed the miRNAs of HHV-6A: miR-U86, and −6B: hhv6b-miR-Ro6-1, −2, −3-3p, −3-5p, and −4 in paired samples of serum and CSF of 42 untreated MS patients and 23 patients with other neurological diseases (OND), using Taqman MicroRNA Assays. Intrathecal HHV-6A/B antibody production and anti-HHV-6A/B IgG/IgM levels in serum were measured. MS clinical data were available. We detected the following miRNAs: hhv6b-miR-Ro6-2 (serum: MS:97.7%, OND:95.7%; CSF: MS:81%, OND:86.4%), 3-3p (serum: MS:4.8%, OND:0%; CSF: MS:2.4%, OND:4.5%), −3-5p (serum: MS:95.2%, OND:91.3%; CSF: MS:50%, OND:54.5%), and miR-U86 (serum: MS:54.8%, OND:47.8%; CSF: MS:11.9%, OND:9.1%). In the serum of the whole population (MS and OND patients) we found a significant correlation between the levels of hhv6b-miR-Ro6-2 and −3-5p (Spearman r = 0.839, pcorr = 3E-13), −2 and miR-U86 (Spearman r = 0.578, pcorr = 0.001) and −3-5p and miR-U86 (Spearman r = 0.698, pcorr = 1.34E-5); also in the CSF, between hhv6b-miR-Ro6-2 and −3-5p (Spearman r = 0.626, pcorr = 8.52E-4). These correlations remained statistically significant when both populations were considered separately. The anti-HHV-6A/B IgG levels in CSF and the intrathecal antibody production in positive MS patients for hhv6b-miR-Ro6-3-5p were statistically significant higher than in the negative ones (pcorr = 0.006 and pcorr = 0.036). The prevalence of miR-U86 (30.8%) in the CSF of individuals without gadolinium-enhancing lesions was higher (p = 0.035) than in the ones with these lesions (0%); however, the difference did not withstand Bonferroni correction (pcorr = 0.105). We propose a role of HHV-6A/B miRNAs in the maintenance of the viral latency state. Further investigations are warranted to validate these results and clarify the function of these viral miRNAs. Frontiers Media S.A. 2020-09-18 /pmc/articles/PMC7531184/ /pubmed/33072077 http://dx.doi.org/10.3389/fimmu.2020.02142 Text en Copyright © 2020 Domínguez-Mozo, Nieto-Guerrero, Pérez-Pérez, García-Martínez, Arroyo and Álvarez-Lafuente. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Domínguez-Mozo, María I.
Nieto-Guerrero, Alejandro
Pérez-Pérez, Silvia
García-Martínez, María Á.
Arroyo, Rafael
Álvarez-Lafuente, Roberto
MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
title MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
title_full MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
title_fullStr MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
title_full_unstemmed MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
title_short MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
title_sort micrornas of human herpesvirus 6a and 6b in serum and cerebrospinal fluid of multiple sclerosis patients
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531184/
https://www.ncbi.nlm.nih.gov/pubmed/33072077
http://dx.doi.org/10.3389/fimmu.2020.02142
work_keys_str_mv AT dominguezmozomariai micrornasofhumanherpesvirus6aand6binserumandcerebrospinalfluidofmultiplesclerosispatients
AT nietoguerreroalejandro micrornasofhumanherpesvirus6aand6binserumandcerebrospinalfluidofmultiplesclerosispatients
AT perezperezsilvia micrornasofhumanherpesvirus6aand6binserumandcerebrospinalfluidofmultiplesclerosispatients
AT garciamartinezmariaa micrornasofhumanherpesvirus6aand6binserumandcerebrospinalfluidofmultiplesclerosispatients
AT arroyorafael micrornasofhumanherpesvirus6aand6binserumandcerebrospinalfluidofmultiplesclerosispatients
AT alvarezlafuenteroberto micrornasofhumanherpesvirus6aand6binserumandcerebrospinalfluidofmultiplesclerosispatients